碳水化合物代谢
新陈代谢
酶
癌细胞
癌症
生物
生物化学
药理学
遗传学
作者
Yi Zhang,Qiong Li,Zhao Huang,Bowen Li,Edouard Collins Nice,Canhua Huang,Liuya Wei,Bingwen Zou
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2022-09-21
卷期号:14 (19): 4568-4568
被引量:153
标识
DOI:10.3390/cancers14194568
摘要
Reprogramming of glucose metabolism provides sufficient energy and raw materials for the proliferation, metastasis, and immune escape of cancer cells, which is enabled by glucose metabolism-related enzymes that are abundantly expressed in a broad range of cancers. Therefore, targeting glucose metabolism enzymes has emerged as a promising strategy for anticancer drug development. Although several glucose metabolism modulators have been approved for cancer treatment in recent years, some limitations exist, such as a short half-life, poor solubility, and numerous adverse effects. With the rapid development of medicinal chemicals, more advanced and effective glucose metabolism enzyme-targeted anticancer drugs have been developed. Additionally, several studies have found that some natural products can suppress cancer progression by regulating glucose metabolism enzymes. In this review, we summarize the mechanisms underlying the reprogramming of glucose metabolism and present enzymes that could serve as therapeutic targets. In addition, we systematically review the existing drugs targeting glucose metabolism enzymes, including small-molecule modulators and natural products. Finally, the opportunities and challenges for glucose metabolism enzyme-targeted anticancer drugs are also discussed. In conclusion, combining glucose metabolism modulators with conventional anticancer drugs may be a promising cancer treatment strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI